Posted by: admin on: September 21, 2011
The US Food and Drug Administration (FDA) announced approval for the use of onabotulinumtoxinA (Botox) to treat urinary incontinence resulting from detrusor over activity in patients with spinal cord injury and multiple sclerosis (MS) -Team@CMHF